Nuclear Medicine Market 2018 | Emerging Trends | Key Players

1
Nuclear Medicine Market
Global Opportunity Analysis and Industry
Forecast, 2014 - 2022
2
Introduction

• Global Nuclear Medicine Market is expected to
  garner 8,207.5 million by 2022. The market is
  currently in its growth stage driven by
  increasing number of cancer cases and rising
  awareness about nuclear medicine.
  Radiopharmaceuticals are pharmaceutical
  formulations comprising radioactive isotopes that
  are used in diagnosis and therapeutics. They are
  simple and small substances that contain a
  radioactive substance that is used in the
  treatment of cancer and cardiac neurological
  disorders.
• The conventional chemotherapy methods are being
  replaced by more convenient therapeutic
  radiopharmaceuticals for oncology and cancer
  treatment, which opens up new avenues in the
  radiopharmaceuticals market. Moreover, it not
  only helps physicians during diagnosis, but also
  works as a convenient and safer alternative for
  patients as compared to X-Rays and other external
  radiation imaging devices.

3
Nuclear Medicine Market
Scope of
the Report
Key Benefits Key Audiences
4
Key Benefits

• This report provides an extensive analysis of the
  current and emerging market trends and dynamics
  in the global nuclear medicine market.
• This report includes a detailed quantitative
  analysis of the current market and estimations
  from 2014 to 2022, which contribute in
  identifying the key market opportunities for
  growth.
• Exhaustive analysis of the global
  radiopharmaceuticals market by type helps in
  understanding the types of radiopharmaceuticals
  that are currently being used along with the
  variants that would gain prominence in the
  future.
• Competitive intelligence (of leading
  manufacturers of radiopharmaceuticals) helps in
  understanding the competitive scenario across the
  geographies.
• Key market players within the radiopharmaceuticals
  market are profiled in this report and their
  strategies are analyzed thoroughly. This helps in
  understanding the competitive outlook of the
  global nuclear medicine market.

5
Table of Content (TOC)

• Chapter 1 Introduction
• Chapter 2 Executive Summary
• Chapter 3 Market Overview
• Chapter 4 World Radiopharmaceuticals Market, By
  Type, 2014-2022
• Chapter 5 World Radiopharmaceuticals Market, By
  Modality, 2014-2022
• Chapter 6 World Radiopharmaceuticals Market, By
  Application, 2014-2022
• Chapter 7 World Radiopharmaceuticals Market, By
  End-user, 2014-2022
• Chapter 8 World Radiopharmaceuticals Market, By
  Geography, 2014-2022
• Chapter 9 Company Profiles

6
Segments
7
Segments
8
Analyst Review

• Radiopharmaceuticals is a medical specialty that
  uses specific radiotracers, and have emerged as
  an efficient imaging technology in the field of
  nuclear medicine. The non-invasive nature of
  radiopharmaceuticals has quickened the diagnosis
  of various diseases such as cardiovascular
  diseases, neurological disorders, and cancers.
  Nowadays, therapeutic radiopharmaceuticals are
  preferred to conventional therapeutic modalities,
  such as chemotherapy, in the field of oncology
  for treating cancers. Radiopharmaceuticals are
  mostly used in diagnostic applications due to
  advancements in the field such as hybrid imaging
  technologies using PET/CT and SPECT/CT.
• Convenient therapeutic radiopharmaceuticals
  procedures have a higher capability of mapping
  physiological functions and metabolic activities
  and providing specific information about organ
  function and dysfunction as compared to
  conventional imaging modalities such as magnetic
  resonance imaging (MRI), computed tomography
  (CT), and ultrasonography (US) among others.
  Furthermore, increase in incidence of cancer
  cardiovascular aliments, growing demand for alpha
  radio immunotherapy-based targeted cancer
  treatment, need for nuclear imaging techniques,
  and advancements in radiotracers have opened new
  avenues for radiopharmaceutical manufactures.

9
Company Profiles

• Mallinckrodt plc.
• General Electric Co.
• Medtronic, plc. (Covidien, acquired by Medtronic)
• Bayer AG
• Cardinal Health, Inc.
• Lantheus Medical Imaging, Inc.

10
Thank You
Thank You! For More Details
Do Enquiry
https//www.alliedmarketresearch.com/nuclear-medic
ine-radiopharmaceuticals-market
Follow Us On